PMA

P890063: GENESIS(R) HOME UTERINE ACTIVITY MONITORING SYSTEM

FDA PMA · Monitor, uterine contraction, external (for use in clinic) · Matria Healthcare, Inc.

Key facts

PMA number P890063
Trade name GENESIS(R) HOME UTERINE ACTIVITY MONITORING SYSTEM
Generic name Monitor, uterine contraction, external (for use in clinic)
Applicant Matria Healthcare, Inc.
Owner/operator Jackson Medical Group
Product code HFM
Approval date Sep 12, 1990
Docket number 90M-0315
Notice date Oct 23, 1990
Establishment registration 3014150062
FEI number 3014150062

At a glance

  • 1–9 Supplements
  • Jun 16, 1995 Latest supplement decision
  • No Withdrawn
  • No Summary of safety and effectiveness on file
  • None UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals